Literature DB >> 822974

Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.

J L Preud'Homme, D Hurez, F Danon, J C Brouet, M Seligmann.   

Abstract

Immunoglobulins were studied at the cellular level by direct immunofluorescence in twenty-five patients with 'nonsecretory' myeloma and thirty-six patiens with Bence-Jones (BJ) myeloma. The results were compared with those obtained in a control group of thirty-six patients with common secretory myeloma. A monoclonal Ig (IgG in eighteen, IgA in three and kappa chains only in three cases) was found in the cytoplasm of the plasma cells from all the patients with 'nonsecretory' myeloma, with a striking dysbalance in the staining brightness for the heavy and the light chains. A similar dysbalance in staining was also observed for plasma cell surface Ig chains but in the opposite way. In twenty patients with BJ myeloma studied for cytoplasmic Ig only, determinants of a heavy chain were clearly found in four cases. When surface Ig were studied also, the production of gamma chains in addition to the light chain could be ascertained in six of sixteen cases. In addition, IgM with the same light chain type as the BJ protein was detected at the cell surface on plasma cells and lymphocytes in two of these sixteen patients. 'Monoclonal' populations of B lymphocytes bearing the same Ig chains as those produced by the myeloma cells were detectable in five of eleven 'nonsecretory' myeloma and in five of sixteen BJ myeloma patients. Normal blood B lymphocytes were in decreased number, particularly when a 'monoclonal' lymphocytic population was detected. Data are discussed which suggest that plasma cells from most patients with 'nonsecretory' myeloma might synthesize and secrete Ig molecules with structurally abnormal chains that are then quickly degraded.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822974      PMCID: PMC1541419     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Myeloma producing nonsecretory IgM and secretory IgG.

Authors:  H Stein; E Kaiserling
Journal:  Scand J Haematol       Date:  1974

2.  Nonsecretory myeloma. Immunofluorescent demonstration of paraprotein within bone marrow plasma cells.

Authors:  W P Arend; J W Adamson
Journal:  Cancer       Date:  1974-03       Impact factor: 6.860

3.  Mutagenesis of mouse myeloma cells with 'Melphalan'.

Authors:  J L Prend'homme; J Buxbaum; M D Scharff
Journal:  Nature       Date:  1973-10-12       Impact factor: 49.962

4.  Multiple myeloma and benign monoclonal gammopathy: differentiation by immunofluorescence of lymphocytes.

Authors:  F D Lindström; W R Hardy; B J Eberle; R C Williams
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

5.  Multiple myeloma without M-type proteinemia. Report of a case with immunologic and ultrastructure studies.

Authors:  J Gach; L Simar; J Salmon
Journal:  Am J Med       Date:  1971-06       Impact factor: 4.965

6.  Heavy chain-producing variants of a mouse myeloma cell line.

Authors:  S L Morrison; M D Scharff
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Immunofluorescent staining of human lymphocytes for the detection of surface immunoglobulins.

Authors:  J L Preud'homme; S Labaume
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

8.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

9.  Intact and fragmented intracellular immunoglobulin in a case of non-secretory myeloma.

Authors:  J T Whicher; J D Davies; J A Grayburn
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

10.  Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.

Authors:  Y Chen; N Bhoopalam; V Yakulis; P Heller
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

View more
  17 in total

1.  Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

Authors:  Shaji Kumar; Waleska S Pérez; Mei-Jie Zhang; Karen Ballen; Asad Bashey; L Bik To; Christopher N Bredeson; Mitchell S Cairo; Gerald J Elfenbein; César O Freytes; Robert Peter Gale; John Gibson; Robert A Kyle; Martha Q Lacy; Hillard M Lazarus; Philip L McCarthy; Gustavo A Milone; Jan S Moreb; Santiago Pavlovsky; Donna E Reece; David H Vesole; Peter H Wiernik; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

2.  Terminal B cell development as seen in different human myelomas and related disorders.

Authors:  G F Burns; C P Worman; B E Roberts; C G Raper; C R Barker; J C Cawley
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

3.  Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.

Authors:  J L Preud'homme; J C Brouet; M Seligmann
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

4.  Immunoglobulin production and secretion in Bence Jones protein myeloma and "nonsecretory" myeloma. Ultrastructural and immunofluorescence study.

Authors:  T Yonezawa; T Kitani; T Tamaki; Y Kanayama; A Hiraoka; S Tarui
Journal:  Blut       Date:  1982-08

5.  PWM-induced generation of immunoglobulin-secreting cells in patients with multiple myeloma.

Authors:  G Sieber; B Enders; H Rühl
Journal:  Klin Wochenschr       Date:  1981-10-01

6.  Differing surface marker characteristics in plasma cell dyscrasias with particular reference to IgM myeloma.

Authors:  G F Burns; J C Cawley; C R Barker; C P Worman; C G Raper; F G Hayhoe
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

7.  Ultrastructural features of the plasma cells in "non-secretory" myeloma.

Authors:  S Weiss; U H Lewinski; A J Pick; U Gafter; M Djaldetti
Journal:  Blut       Date:  1978-03-15

8.  Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.

Authors:  T Gallart; J Bladé; J Martínez-Quesada; J Sierra; C Rozman; J Vives
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

9.  Immunoglobulin synthesis in primary and myeloma amyloidosis.

Authors:  J L Preud'homme; D Ganeval; J P Grünfeld; L Striker; J C Brouet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.

Authors:  J L Preud'Homme; L Morel-Maroger; J C Brouet; E Mihaesco; J P Mery; M Seligmann
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.